Neuroplastic effects of a selective serotonin reuptake inhibitor in relearning and retrieval

• Published in: NeuroImage (Orlando, Fla.) Fla.), 2021-08, Vol.236, p.118039-118039, Article 118039
• Main Authors: Reed, M.B., Vanicek, T., Seiger, R., Klöbl, M., Spurny, B., Handschuh, P., Ritter, V., Unterholzner, J., Godbersen, G.M., Gryglewski, G., Kraus, C., Winkler, D., Hahn, A., Lanzenberger, R.
• Format: Article
• Language: English
• Subjects: Adult; Angular gyrus; Antidepressants; Association Learning - drug effects; Associative learning; Brain Mapping; Cerebral Cortex - diagnostic imaging; Cerebral Cortex - drug effects; Cerebral Cortex - physiology; Citalopram; Citalopram - administration & dosage; Citalopram - pharmacology; Cognitive ability; Deactivation; DNA methylation; Double-Blind Method; Female; fMRI; Functional magnetic resonance imaging; Humans; Insula; Investigations; Learning; Longitudinal Studies; Magnetic Resonance Imaging; Male; Mathematical models; Memory; Mental disorders; Mental Recall - drug effects; Neuronal Plasticity - drug effects; Neuroplasticity; Parietal Lobe - diagnostic imaging; Parietal Lobe - drug effects; Parietal Lobe - physiology; Participation; Pattern Recognition, Visual - physiology; Placebos; Relearning; Serotonin; Serotonin uptake inhibitors; Serotonin Uptake Inhibitors - administration & dosage; Serotonin Uptake Inhibitors - pharmacology; SSRI; Translation; Young Adult
• ISSN: 1053-8119; 1095-9572
• DOI: 10.1016/j.neuroimage.2021.118039

Animal studies using selective serotonin reuptake inhibitors (SSRIs) and learning paradigms have demonstrated that serotonin is important for flexibility in executive functions and learning. SSRIs might facilitate relearning through neuroplastic processes and thus exert their clinical effects in psychiatric diseases where cognitive functioning is affected. However, translation of these mechanisms to humans is missing. In this randomized placebo-controlled trial, we assessed functional brain activation during learning and memory retrieval in healthy volunteers performing associative learning tasks aiming to translate facilitated relearning by SSRIs. To this extent, seventy-six participants underwent three MRI scanning sessions: (1) at baseline, (2) after three weeks of daily associative learning and subsequent retrieval (face-matching or Chinese character–noun matching) and (3) after three weeks of relearning under escitalopram (10 mg/day) or placebo. Associative learning and retrieval tasks were performed during each functional MRI (fMRI) session. Statistical modeling was done using a repeated-measures ANOVA, to test for content-by-treatment-by-time interaction effects. During the learning task, a significant substance-by-time interaction was found in the right insula showing a greater deactivation in the SSRI cohort after 21 days of relearning compared to the learning phase. In the retrieval task, there was a significant content-by-time interaction in the left angular gyrus (AG) with an increased activation in face-matching compared to Chinese-character matching for both learning and relearning phases. A further substance-by-time interaction was found in task performance after 21 days of relearning, indicating a greater decrease of performance in the placebo group. Our findings that escitalopram modulate insula activation demonstrates successful translation of relearning as a mechanism of SSRIs in human. Furthermore, we show that the left AG is an active component of correct memory retrieval, which coincides with previous literature. We extend the function of this region by demonstrating its activation is not only stimulus dependent but also time constrained. Finally, we were able to show that escitalopram aids in relearning, irrespective of content.